Concepedia

Author

Venkateswarlu Akella

Dr. Reddy's Foundation

Also Known As

Akella Venkateswarlu, Venkateswarlu Akella

14

Publications

391

Citations

8

H-Index

23

Concepts

All Affiliations

Dr. Reddy's FoundationDr. Reddy's Laboratories (India)Dr. Reddy's Laboratories (United States)
VA

About

Venkateswarlu Akella is an author at Dr. Reddy's Foundation specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

347

2

Biochemistry

2

2

248

3

Natural Sciences

1

1

60

4

Biomolecular Engineering

1

1

26

5

Cell Biology

1

1

16

Venkateswarlu Akella

×

8

Publications

385

Citations

8

H-Index

YearCitations

Synthesis and structure–activity relationships of andrographolide analogues as novel cytotoxic agents

Srinivas Nanduri, Vijay Kumar Nyavanandi, Siva Sanjeeva Rao Thunuguntla,

Bioorganic & Medicinal Chemistry Letters

2004

188

3-O-Substituted benzyl pyridazinone derivatives as COX inhibitors

Vamsee Krishna Chintakunta, Venkateswarlu Akella, Manohar Sharma Vedula,

European Journal of Medicinal Chemistry

2002

60

New styryl sulfones as anticancer agents

Manohar Sharma Vedula, Aravind Babu Pulipaka, Chandrasekhar Venna,

European Journal of Medicinal Chemistry

2003

46

Novel C-ring analogues of 20(S)-camptothecin-part-2: Synthesis and cytotoxicity of 5-C-substituted 20(S)-camptothecin analogues

Duvvuri Subrahmanyam, Venkateswarlu Akella, Kalla Venkateswara Rao,

Bioorganic & Medicinal Chemistry Letters

1999

26

Novel C-ring analogues of 20(S)-camptothecin. Part 3: synthesis and their in vitro cytotoxicity of A-, B- and C-ring analogues

Duvvuri Subrahmanyam, Vedula M. Sarma, Venkateswarlu Akella,

Bioorganic & Medicinal Chemistry Letters

2000

25

Antitumor bicyclic hexapeptide RA-VII modulates cyclin D1 protein level

Kenichi Wakita, Megumi Minami, Venkateswarlu Akella,

Anti-Cancer Drugs

2001

16

2-Hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-1H-1-pyrazolyl]-1-benzenesulfonamide (DRF-4367): an orally active COX-2 inhibitor identified through pharmacophoric modulation

Sunil Kumar Singh, Saibaba Vobbalareddy, Srinivasa Rao Kalleda,

Organic & Biomolecular Chemistry

2004

13

A DNAzyme based knockdown model for Fragile-X syndrome in zebrafish reveals a critical window for therapeutic intervention

Raghavender Medishetti, Rita Rani, Srinivas Kavati,

Journal of Pharmacological and Toxicological Methods

2019

11

Page 1